XML 20 R11.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Investments | 6 Months Ended
--- | ---
Mar. 31, 2022
Investments, Debt and Equity Securities [Abstract] |
INVESTMENTS | 5. INVESTMENTS The following tables summarize investments by type of security as of March 31, 2022 and September 30, 2021 (amounts shown in thousands):
March 31, 2022: | Cost |  | Gross Unrealized Gains |  | Gross Unrealized Losses |  | Fair Market Value
Available-for-sale securities: |  |  |  |  |  |  |
U.S. Treasury, short-term | $ | 2,000 |  |  | $ | — |  |  | $ | (20) |  |  | $ | 1,980 |
Foreign government and agency securities, short-term | 2,888 |  |  | — |  |  | (38) |  |  | 2,850 |
Corporate debt securities, short-term | 33,446 |  |  | — |  |  | (366) |  |  | 33,080 |
U.S. Treasury, long-term | 7,481 |  |  | — |  |  | (215) |  |  | 7,266 |
Corporate debt securities, long-term | 24,743 |  |  | — |  |  | (516) |  |  | 24,227 |
Total | $ | 70,558 |  |  | $ | — |  |  | $ | (1,155) |  |  | $ | 69,403 |
September 30, 2021: | Cost |  | Gross Unrealized Gains |  | Gross Unrealized Losses |  | Fair Market Value
Available-for-sale securities: |  |  |  |  |  |  |
U.S. Treasury, short-term | $ | 4,222 |  |  | $ | 1 |  |  | $ | — |  |  | $ | 4,223 |
Asset-backed securities, short-term | 4,812 |  |  | 1 |  |  | (2) |  |  | 4,811 |
Corporate debt securities, short-term | 140,042 |  |  | 6 |  |  | (25) |  |  | 140,023 |
U.S. Treasury, long-term | 6,996 |  |  | 1 |  |  | (2) |  |  | 6,995 |
Foreign government and agency securities, long-term | 2,909 |  |  | — |  |  | (1) |  |  | 2,908 |
Corporate debt securities, long-term | 38,184 |  |  | 3 |  |  | (39) |  |  | 38,148 |
Total | $ | 197,165 |  |  | $ | 12 |  |  | $ | (69) |  |  | $ | 197,108 |
The cost of securities sold is based on the specific identification method. Amortization of premiums, accretion of discounts, interest, dividend income and realized gains and losses are included in other income (expense), net in the consolidated statements of operations and comprehensive income (loss). The Company determines the appropriate designation of investments at the time of purchase and reevaluates such designation as of each balance sheet date. All of the Company’s investments are designated as available-for-sale debt securities. As of March 31, 2022 and September 30, 2021, the Company’s short-term investments have maturity dates of less than one year from the balance sheet date and the Company’s long-term investments have maturity dates of greater than one year from the balance sheet date. Available-for-sale marketable securities are carried at fair value as determined by quoted market prices for identical or similar assets, with unrealized gains and losses, net of taxes, and are reported as a separate component of stockholders’ equity. Management reviews the fair value of the portfolio at least monthly and evaluates individual securities with fair value below amortized cost at the balance sheet date. For debt securities, in order to determine whether impairment is other-than-temporary, management must conclude whether the Company intends to sell the impaired security and whether it is more likely than not that the Company will be required to sell the security before recovering its amortized cost basis. If management intends to sell an impaired debt security or it is more likely than not that the Company will be required to sell the security prior to recovering its amortized cost basis, an other-than-temporary impairment is deemed to have occurred. The amount of an other-than-temporary impairment on debt securities related to a credit loss, or securities that management intends to sell before recovery, is recognized in earnings. The amount of an other-than-temporary impairment on debt securities related to other factors is recorded consistent with changes in the fair value of all other available-for-sale securities as a component of stockholders’ equity in other comprehensive income. No other-than-temporary impairment charges were recognized in each of the three and six months ended March 31, 2022 and 2021. There were $0.3 million of realized losses from the sale of available-for-sale securities during each of the three and six months ended March 31, 2022 and no realized gains or losses from the sale of available-for-sale securities during each of the three and six months ended March 31, 2021. Fair Value Measurements and Disclosures FASB ASC Topic 820, Fair Value Measurements (“ASC 820”) defines fair value, establishes a framework for measuring fair value under GAAP and enhances disclosures about fair value measurements. Fair value is defined under ASC 820 as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value under ASC 820 must maximize the use of observable inputs and minimize the use of unobservable inputs. ASC 820 describes a fair value hierarchy based on the following three levels of inputs that may be used to measure fair value, of which the first two are considered observable and the last, unobservable: •Level 1—Quoted prices in active markets for identical assets or liabilities; •Level 2—Inputs other than Level 1 inputs that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and •Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The following tables represent the fair value hierarchy of the Company’s investments, convertible senior notes hedge, acquisition-related contingent consideration, and embedded conversion derivative as of March 31, 2022 and September 30, 2021, respectively (amounts shown in thousands):
March 31, 2022: | Balance |  | Quoted Prices in Active Markets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3)
Assets: |  |  |  |  |  |  |
Short-term investments: |  |  |  |  |  |  |
U.S. Treasury | $ | 1,980 |  |  | $ | 1,980 |  |  | $ | — |  |  | $ | — |
Foreign government and agency securities | 2,850 |  |  | — |  |  | 2,850 |  |  | — |
Corporate debt securities | 33,080 |  |  | — |  |  | 33,080 |  |  | — |
Total short-term investments at fair value | 37,910 |  |  | 1,980 |  |  | 35,930 |  |  | — |
Long-term investments: |  |  |  |  |  |  |
U.S. Treasury | 7,266 |  |  | 7,266 |  |  | — |  |  | — |
Corporate debt securities | 24,227 |  |  | — |  |  | 24,227 |  |  | — |
Total long-term investments at fair value | 31,493 |  |  | 7,266 |  |  | 24,227 |  |  | — |
Total assets at fair value | $ | 69,403 |  |  | $ | 9,246 |  |  | $ | 60,157 |  |  | $ | — |
Liabilities: |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |
Acquisition-related contingent consideration | $ | 10,790 |  |  | $ | — |  |  | $ | — |  |  | $ | 10,790 |
Non-current liabilities: |  |  |  |  |  |  |
Acquisition-related contingent consideration | 5,200 |  |  | — |  |  | — |  |  | 5,200 |
Total liabilities at fair value | $ | 15,990 |  |  | $ | — |  |  | $ | — |  |  | $ | 15,990 |
September 30, 2021: | Balance |  | Quoted Prices in Active Markets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3)
Assets: |  |  |  |  |  |  |
Short-term investments: |  |  |  |  |  |  |
U.S. Treasury | $ | 4,223 |  |  | $ | 4,223 |  |  | $ | — |  |  | $ | — |
Asset-backed securities, short-term | 4,811 |  |  | — |  |  | 4,811 |  |  | — |
Corporate debt securities | 140,023 |  |  | — |  |  | 140,023 |  |  | — |
Total short-term investments at fair value | 149,057 |  |  | 4,223 |  |  | 144,834 |  |  | — |
Long-term investments: |  |  |  |  |  |  |
U.S. Treasury | 6,995 |  |  | 6,995 |  |  | — |  |  | — |
Foreign government and agency securities | 2,908 |  |  | — |  |  | 2,908 |  |  | — |
Corporate debt securities | 38,148 |  |  | — |  |  | 38,148 |  |  | — |
Total long-term investments at fair value | 48,051 |  |  | 6,995 |  |  | 41,056 |  |  | — |
Convertible senior notes hedge | 48,208 |  |  | — |  |  | 48,208 |  |  | — |
Total assets at fair value | $ | 245,316 |  |  | $ | 11,218 |  |  | $ | 234,098 |  |  | $ | — |
Liabilities: |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |
Acquisition-related contingent consideration | $ | 11,050 |  |  | $ | — |  |  | $ | — |  |  | $ | 11,050 |
Non-current liabilities: |  |  |  |  |  |  |
Acquisition-related contingent consideration | 5,720 |  |  | — |  |  | — |  |  | 5,720 |
Embedded conversion derivative | 48,208 |  |  | — |  |  | 48,208 |  |  | — |
Total liabilities at fair value | $ | 64,978 |  |  | $ | — |  |  | $ | 48,208 |  |  | $ | 16,770 |
•Level 1: Includes investments in U.S. Government and agency securities, which are valued based on recently executed transactions in the same or similar securities. •Level 2: Convertible Senior Notes. On February 5, 2021, the Company issued the 2026 Notes as further described in Note 9. “Convertible Senior Notes.” Concurrently with the issuance of the 2026 Notes, the Company entered into the Notes Hedge and Warrant Transactions which in combination are intended to reduce the potential dilution from the conversion of the 2026 Notes. Initially, conversion of the 2026 Notes could only be settled in cash; however, following the increase in the Company’s authorized shares of Common Stock in the second quarter of fiscal 2022, which satisfied certain share reservation conditions, conversion of the 2026 Notes may be settled in cash, shares of Common Stock or a combination of cash and shares of Common Stock, at the Company’s election. The embedded conversion derivative associated with the 2026 Notes previously meet the criteria for an embedded derivative liability which required bifurcation and separate accounting. The Notes Hedge was previously classified as a derivative asset on the Company’s consolidated balance sheet. Following the increase in the Company’s authorized shares of Common Stock in the second quarter of fiscal 2022, the Notes Hedge and embedded conversion derivative were reclassified to additional paid-in capital as the equity classification criteria is met. Changes in the fair value of these derivatives prior to being classified in equity were reflected in Other income (expense), net, in the Company’s consolidated statement of operations and comprehensive income (loss). The fair value of the Notes Hedge and the embedded conversion derivative were estimated using a Black-Scholes model. Based on the fair value hierarchy, the Company classified the Notes Hedge and the embedded conversion derivative as Level 2 as significant inputs are observable, either directly or indirectly. The significant inputs and assumptions used in the models to calculate the fair value of the derivatives include the Common Stock price, exercise price of the derivatives, risk-free interest rate, volatility, annual coupon rate and remaining contractual term. •Level 3: As of March 31, 2022, total acquisition-related contingent consideration of $10.8 million and $5.2 million is recorded in acquisition-related contingent consideration and other non-current liabilities, respectively, in the consolidated balance sheets. The following table includes a summary of the contingent consideration measured at fair value using significant unobservable inputs (Level 3) during the six months ended March 31, 2022 (amounts shown in thousands):
Balance at September 30, 2021 | $ | 16,770 |
Expenses recorded due to changes in fair value | (780) |
Balance at March 31, 2022 | $ | 15,990 |

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for investments in certain debt and equity securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 320 -URI http://asc.fasb.org/subtopic&trid=2209399 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 320 -URI http://asc.fasb.org/subtopic&trid=2324412 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -URI http://asc.fasb.org/topic&trid=2196928 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 940 -SubTopic 320 -URI http://asc.fasb.org/subtopic&trid=2176304 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-K (SK) -Number 229 -Section 1403 -Paragraph (b) + Details
Name: | us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration